Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes
Victor A. Gault*, Nigel Irwin, Brian D. Green, Jane T. McCluskey, Brett Greer, Clifford Bailey, Patrick Harriott, Finbarr P.M. O'Harte, Peter R. Flatt
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes'. Together they form a unique fingerprint.